A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy

Epilepsy is one of the most common chronic neurological diseases, and its pharmacological treatment holds great importance for both physicians and national authorities, especially considering the high proportion of drug-resistant patients (about 30%). Lacosamide (LCM) is an effective and well-tolera...

詳細記述

書誌詳細

主要な著者:	Gabriele Ruffolo, Carlo Di Bonaventura, Pierangelo Cifelli, Cristina Roseti, Jinane Fattouch, Alessandra Morano, Cristina Limatola, Eleonora Aronica, Eleonora Palma, Anna Teresa Giallonardo
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2018-07-01
シリーズ:	Neurobiology of Disease
主題:	Epilepsy GABAA receptor Drug-resistance Lacosamide Levetiracetam Xenopus oocytes
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S0969996118300949
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!